Activated platelets in subjects at increased risk of IDDM

Diabetologia

Volumn 40, Issue 5, 1997, Pages 573-577

  Tschoepe, D ^a   Driesch, E ^a   Schwippert, B ^a   Lampeter, E F ^a  

^a LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

Author keywords

activated platelets; islet cell antibodies; prediabetic

Indexed keywords

PADGEM PROTEIN; PANCREAS ISLET CELL ANTIBODY; THROMBOSPONDIN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION;

ADULT; ANTIGENS, CD; AUTOANTIBODIES; BLOOD PLATELETS; CONFIDENCE INTERVALS; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; ISLETS OF LANGERHANS; MALE; MEMBRANE GLYCOPROTEINS; P-SELECTIN; PLATELET ACTIVATION; PLATELET MEMBRANE GLYCOPROTEINS; RISK ASSESSMENT; RISK FACTORS; THROMBOSPONDINS;

EID: 0030945072     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050717     Document Type: Article

References (18)

1. Tschoepe D, Schwippert B, Schettler B, Kiesel U, Rothe H, Roesen P, Gries FA (1992) Increased GPIIB/IIIA expression and altered DNA-ploidy pattern in megakaryocytes of diabetic BB-rats. Eur J Clin Invest 22: 591-598
2. Tschoepe D, Driesch E, Schwippert B, Nieuwenhuis HK, Gries FA (1995) Increased exposure of adhesion molecules on activated platelets is not normalized by near normoglycemic control. Diabetes 44: 890-894
3. Lampeter E, Kishimoto TK, Rothlein R et al. (1992) Elevated levels of circulating adhesion molecules in IDDM patients and in subjects at risk for IDDM. Diabetes 41: 1668-1671
4. Lampeter EF, Klinghammer A, Haastert B et al. and the Denis Study Group (1994) Die Deutsche Nikotinamid Interventions Studie - DENIS; Erster Zwischenbericht zu Screening und Rekrutierung. Diab Stoffw 3: 397-403
5. Valet G, Valet M, Tschoepe D, Gabriel H, Rothe G, Kellermann W, Kahle H (1993) White cell and thombocyte disorders. Standardized, self-learning flow cytometric list mode data classification with the CLASSIF1 program system. Ann NY Acad Sci 677: 233-251
6. Kolb H, Dannehl K, Grüneklee D (1988) Prospective analysis of islet-cell antibodies in children with TDDM. Diabetologia 31: 189-194
7. Tschoepe D, Schultheiss HP, Kolarov P et al. (1993) Platelet membrane activation markers are predictive for increased risk of acute ischemic events after PTCA. Circulation 88: 37-42
8. McEver RP (1991) Selectins: novel receptors that mediate leukocyte adhesion during inflammation. Thromb Haemostas 65: 223-228
9. Palabricia T, Lobb R, Furie BC et al. (1992) Leukocyte accumulation promoting fibrin deposition is mediated in vivo by p-selectin on adherent platelets. Nature 359: 848-851
10. Collins CE, Cahill MR, Newland AC, Rampton DS (1994) Platelets circulate in an activated state in inflammatory bowel disease. Gastroenterology 106: 840-845
11. Wakefield AJ, Dhillon AP, Rowles PM, Sawyer AM, Pittilo RM, Lewis AAM (1989) Pathogenesis of Crohns's disease: multifocal gastrointestinal infarction. Lancet II: 1057-1062
12. Ikehara S, Inaba M, Yasumizu R et al. (1994) Autoimmune diseases as stem cell disorders. Tohoku J Exp Med 173: 141-155
13. Weyrich AS, Elstad MR, McEver RP et al. (1996) Activated platelets signal chemokine synthesis by human monocytes. J Clin Invest 97: 1525-1534
14. Kaplanski G, Porat R, Aiura K, Erban JK, Gelfand JA, Dinarello CA (1993) Activated platelets induce endothelial secretion of interleukin-8 in vitro via an interleukin-1-mediated event. Blood 81: 2492-2495
15. Ricordi C, Murase N, Rastellini C, Behboo R, Demetris AJ, Starzl TE (1994) Donor bone marrow cell infusion without recipient cytoablation induces acceptance of rat islet allografts. Transplant Proc 26: 3358
16. Lampeter E, Homberg M, Quabeck K et al. (1993) Transfer of insulin dependent diabetes between HLA-identical siblings by bone marrow transplantation. Lancet 341: 1243-1244
17. Campbell IL, Harrison LC (1990) Molecular pathology of type 1 diabetes. Mol Biol Med 7: 299-309
18. Jobe LW, Ubungen R, Goodner CJ, Baskin DG, Braquet P, Lernmark A (1993) Protection from BB rat diabetes by the platelet-activating factor inhibitor BN50730. Autoimmunity 16: 259-266